Boehringer’s Spesolimab Wins First Approval In Rare Skin Condition

May Commercialize Therapy Alone

 
• By Ayisha Sharma
Start track. Lanes 1, number one of a red racing track.
The US Nod Marks Boehringer's First Major New Drug Approval In Years • Source: Shutterstock

More from New Products

More from Scrip